Scientific Reports · 2018 · 24 citations · 31 references
MedicineImmunologyOncologyCancer ImmunologyImmunoregulationTumor ImmunologyCancer ImmunotherapyFc EngineeringGene Fusions In CancerImmune FunctionImmunotherapy For Breast CancerProtein Expression EngineeringAntibody Fc Fusion ProteinsAntitumor Immune ActivationCd4+ Tumor-infiltrating LymphocytesCd8+ Tumor-infiltrating LymphocytesCd86 InteractionsFc Fusion Protein ExpressionImmune System ModulationSerum Half-life
Thymosin alpha 1 (Tα1) is a biological response modifier that has been introduced into markets for treating several diseases. Given the short serum half-life of Tα1 and the rapid development of Fc fusion proteins, we used genetic engineering method to construct the recombinant plasmid to express Tα1-Fc (Fc domain of human IgG4) fusion protein. A single-factor experiment was performed with different inducers of varying concentrations for different times to get the optimal condition of induced expression. Pure proteins higher than 90.3% were obtained by using 5 mM lactose for 4 h with a final production about 160.4 mg/L. The in vivo serum half-life of Tα1-Fc is 25 h, almost 13 times longer than Tα1 in mice models. Also, the long-acting protein has a stronger activity in repairing immune injury through increasing number of lymphocytes. Tα1-Fc displayed a more effective antitumor activity in the 4T1 and B16F10 tumor xenograft models by upregulating CD86 expression, secreting IFN-γ and IL-2, and increasing the number of tumor-infiltrating CD4+ T and CD8+ T cells. Our study on the novel modified Tα1 with the Fc segment provides valuable information for the development of new immunotherapy in cancer.
31
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
Edith M. Janssen, Edward E. Lemmens, Tom Wolfe et al. · Nature · 2003 · 1.6K citations
Tumor-Infiltrating CD8<sup>+</sup>Lymphocytes Predict Clinical Outcome in Breast Cancer
Sahar Mahmoud, Emma C. Paish, Desmond G. Powe et al. · Journal of Clinical Oncology · 2011 · 1.4K citations · Full text
Life Sciences, Immunology, Oncology +17
Tissue Processing and Hematoxylin and Eosin Staining
Ada T. Feldman, Delia Wolfe · Methods in molecular biology · 2014 · 1.1K citations
Medicine, Cell Biology, Pathology +13
CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome
Yi Huang, Chunling Ma, Qunyuan Zhang et al. · Oncotarget · 2015 · 214 citations · Full text
Medicine, Immunology, Oncology +16